Home
    • Plans Blog Contact
    The Joint Corp logo

    The Joint Corp

    JYNT
    Last price US$8.38
    Market cap US$128.0m
    12M price change -22.01%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Universal Health Services IncUHS Industry peer DaVita HealthCare Partners IncDVA Industry peer CHEMED CORPCHE Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    The Joint Corp Overview

    Industry: Medical Care Facilities

    Sector: Healthcare

    The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona. The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. The Joint Corp. was incorporate Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for The Joint Corp into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 06, 2026

    Quarterly result summary

    Revenue was $30M (+14% YoY); EPS was $0.05 (reported).

    Revenue $30M +14% YoY
    EPS $0.05 reported
    Net income $0.7M +602% YoY
    Adjusted EBITDA $3.2M reported

    What changed

    • Revenue +14% YoY to $30M; EPS reported to $0.05.
    • Capital return update: free cash flow $1.9M.
    • Net income +602% YoY to $0.7M.

    Guidance / outlook

    we expect our pure-play franchisor model to drive margin improvement, profitability and continued free cash flow.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing FORM 10-Q Aug 07, 2026 SEC filing FORM 8-K Aug 06, 2026 Earnings material EXHIBIT-99.2 Aug 06, 2026 SEC filing FORM 10-Q May 08, 2026 Earnings release EXHIBIT-99.1 May 07, 2026 SEC filing FORM 8-K May 07, 2026 Earnings material EXHIBIT-99.2 May 07, 2026 SEC filing FORM 10-K Mar 13, 2026 SEC filing FORM 8-K Mar 12, 2026 Earnings release EXHIBIT-99.1 Mar 12, 2026 Earnings release EXHIBIT-99.2 Mar 12, 2026

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 2.00/5
    The Joint Corp earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , CHEMED CORP are companies with high ratings.

    Return on Equity

    Score 2.63/5
    The Joint Corp stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    The Joint Co... JYNT US$128.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 2.60/5
    The Joint Corp commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    The Joint Co... JYNT US$128.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Care Facilities industry , Universal Health Services Inc , DaVita HealthCare Partners Inc , CHEMED CORP are companies with high ratings.

    Leverage

    Score 1.37/5
    The Joint Corp registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    The Joint Co... JYNT US$128.0m
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    The Joint Corp logo

    The Joint Corp

    US$8.38

    US$1.95

    -76.8% vs price

    US$128.0m

    1.95%

    -22.01%